Early OA: point of no return or a chance for regenerative approaches

Osteoarthritis is one of the main burdens of the twenty-first
century. It is associated with both the functional impairment
of patients and enormous treatment costs for the healthcare
system. For this reason, the diagnosis of “osteoarthritis”offers immense potential for cost reductions for healthcare
providers by narrowing the therapeutic spectrum. It appears
that they favour—in our view, too early—end-stage therapy
with the implantation of heavy metal in joints. Cost reductions
can actually be achieved by healthcare providers by
cutting reimbursements for conservative treatment and
regenerative treatment approaches.